Stealth and Opportunism: Alternative lifestyles of species in the fungal genus Pneumocystis

Annual Review of Microbiology

Volumn 64, Issue , 2010, Pages 431-452

  Cushion, Melanie T ^a,b   Stringer, James R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AIDS related; opportunistic infection; PCP; Pneumocystis

Indexed keywords

GLYCOPROTEIN; MAJOR SURFACE GLYCOPROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; CHROMOSOME; DISEASE TRANSMISSION; FUNGAL COLONIZATION; FUNGAL LIFE CYCLE STAGE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; MOLECULAR PHYLOGENY; NONHUMAN; PNEUMOCYSTIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; TAXONOMY; TELOMERE;

ANIMALS; CHROMOSOMES, FUNGAL; CHRONIC DISEASE; FUNGAL PROTEINS; GENE ORDER; GENES, FUNGAL; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC FACTORS; LUNG; MAMMALS; MEMBRANE GLYCOPROTEINS; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; SYNTENY;

FUNGI; MAMMALIA; PNEUMOCYSTIS;

EID: 77957946019     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.112408.134335     Document Type: Review

References (117)

1. Ambrose HE, Keely SP, Aliouat EM, Dei-Cas E, Wakefield AE, et al. 2004. Expression and complexity of the PRT1 multigene family of Pneumocystis carinii. Microbiology 150:293-300
2. Barton EG Jr, Campbell WG Jr. 1969. Pneumocystis carinii in lungs of rats treated with cortisone acetate. Ultrastructural observations relating to the life cycle. Am. J. Pathol. 54:209-36
3. Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, et al. 2000. Genetic variation in Pneumocys-tis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. 6(3):265-72
4. Bishop R, Gurnell J, Laakkonen J, Whitwell K, Peters S. 1997. Detection of Pneumocystis DNA in the lungs of several species of wild mammal. J. Eukaryot. Microbiol. 44:57S
5. Boonsarngsuk V, Sirilak S, Kiatboonsri S. 2009. Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors. Int. J. Infect. Dis. 13:59-66
6. Brinkmann B,KlintscharM, Neuhuber F, Hohne J, Rolf B.1998. Mutation rate in human microsatellites: influence of the structure and length of the tandem repeat. Am. J. Hum. Genet. 62:1408-15
7. Carini A. 1910. Formas de eschizogonia do Trypanosoma lewisi. Com. Soc. Med. Sao Paulo 1910:204
8. Chagas C. 1909. Nova tripanozomiase humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotry-panum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem. Inst. Oswaldo Cruz 1:159-218
9. Chen CJ, Elkins C, Sparling PF. 1998. Phase variation of hemoglobin utilization in Neisseria gonorrhoeae. Infect. Immun. 66:987-93
10. Cornillot E, Keller B, Cushion MT, Metenier G, Vivares CP. 2002. Fine analysis of the Pneumocystis carinii f. sp. carinii genome by two-dimensional pulsed-field gel electrophoresis. Gene 293:87-95
11. Cushion MT, Arnold J. 1997. Proposal for a Pneumocystis genome project. J. Eukaryot. Microbiol. 44:7S
12. Cushion MT, Collins MS, Linke MJ. 2009. Biofilm formation by Pneumocystis spp. Eukaryot. Cell 8:197-206
13. Cushion MT, Keely SP, Stringer JR. 2005. Validation of the name Pneumocystis wakefieldiae. Mycologia 97:268
14. Cushion MT. Pneumocystis pneumonia. 2005. In Topley & Wilson's Medical Mycology, ed. WG Merz, RJ Hay, 37:763-806. Washington, DC: Hodder Arnold. 869 pp.
15. Cushion MT, Linke MJ, Ashbaugh A, Sesterhenn T, Collins MS, et al. 2010. Echinocandin treatment of Pneumocystis pneumonia in rodent models depletes cysts leaving significant trophic burdens that cannot transmit the infection. PLoS ONE 5(1):e8524
16. Cushion MT, Smulian AG, Slaven BE, Sesterhenn T, Arnold J, et al. 2007. Transcriptome of Pneumocystis carinii during fulminate infection: carbohydrate metabolism and the concept of a compatible parasite. PLoS ONE 2:e423
17. D'Avignon LC, Schofield CM, Hospenthal DR. 2008. Pneumocystis pneumonia. Semin. Respir. Crit. Care Med. 29:132-40
18. Dei-Cas E, Chabe M, Moukhlis R, Durand-Joly I, Aliouat el M, et al. 2006. Pneumocystis oryctolagi sp. nov., an uncultured fungus causing pneumonia in rabbits at weaning: review of current knowledge, and description of a new taxon on genotypic, phylogenetic and phenotypic bases. FEMS Microbiol. Rev. 30:853-71
19. Deitsch KW, Lukehart SA, Stringer JR. 2009. Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens. Nat. Rev. Microbiol. 7:493-503
20. Delanoë P, Delanoë M. 1912. Sur les rapports des kystes de Carini du poumon des rats avec le Trypanosoma lewisi. Crit. Rev. Acad. Sci. 155:658-60
21. Demanche C, Petit T, Moisson P, Ollivet F, Rigoulet J, et al. 2003. Assessment of Pneumocystis species carriage in captive primates. Vet. Rec. 152:811-13
22. Edman JC, Hatton TW, Nam M, Turner R, Mei Q, et al. 1996. A single expression site with a conserved leader sequence regulates variation of expression of the Pneumocystis carinii family of major surface glycoprotein genes. DNA Cell Biol. 15:989-99
23. Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519-22
24. Fisk DT, Meshnick S, Kazanjian PH. 2003. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin. Infect. Dis. 36:70-78
25. Fisk M, Sage EK, Edwards SG, Cartledge JD, Miller RF. 2009. Outcome from treatment of Pneumocystis jirovecii pneumonia with cotrimoxazole. Int. J. STD AIDS 20:652-53
26. Frenkel JK. 1976. Pneumocystis jiroveci n. sp. from man: morphology, physiology, and immunology in relation to pathology. I. The organism and the patient. Natl. Cancer Inst. Monogr. 43, pp. 13-30, US Dept. Health Educ. Welfare, Bethesda, Maryland
27. Frenkel JK. 1999. Pneumocystis pneumonia, an immunodeficiency-dependent disease (IDD): a critical historical overview. J. Eukaryot. Microbiol. 46:89S-92S
28. Gajdusek DC. 1957. Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 19:543-65
29. Garbe TR, Stringer JR. 1994. Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii. Infect. Immun. 62:3092-101
30. Gigliotti F, Haidaris PJ, Haidaris CG, Wright TW, Van der Meid KR. 1993. Further evidence of host species-specific variation in antigens of Pneumocystis carinii using the polymerase chain reaction. J. Infect. Dis. 168:191-94
31. Goldman DL, Huffnagle GB. 2009. Potential contribution of fungal infection and colonization to the development of allergy. Med. Mycol. 47:445-56
32. Graham SM. 2007. HIV-related pulmonary disorders: practice issues. Ann. Trop. Paediatr. 27:243-52
33. Guillot J, Chevalier V, Queney G, Berthelemy M, Polack B, et al. 1999. Acquisition and biodiversity of Pneumocystis carinii in a colony of wild rabbits (Oryctolagus cuniculus). J. Eukaryot. Microbiol. 46:100S-1S
34. Haidaris CG, Medzihradsky OF, Gigliotti F, Simpson-Haidaris PJ. 1998. Molecular characterization of mouse Pneumocystis carinii surface glycoprotein A. DNA Res. 5:77-85
35. Hee SQ. 2003. Exposure routes. In Biological Monitoring: An Introduction, ed. SQ Hee, pp. 78-82. New York: Van Nostrand Reinhold
36. Hong ST, Steele PE, Cushion MT, Walzer PD, Stringer SL, Stringer JR. 1990. Pneumocystis carinii karyotypes. J. Clin. Microbiol. 28:1785-95
37. Huang L, Beard CB, Creasman J, Levy D, Duchin JS, et al. 2000. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J. Infect. Dis. 182:1192-98
38. Huang SN, Angus CW, Turner RE, Sorial V, Kovacs JA. 1999. Identification and characterization of novel variant major surface glycoprotein gene families in rat Pneumocystis carinii. J. Infect. Dis. 179:192-200
39. Hughes WT, McNabb PC, Makres TD, Feldman S. 1974. Efficacy of trimethoprim and sulfamethoxa-zole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother. 5:289-93
40. Icenhour CR, Rebholz SL, Collins MS, Cushion MT. 2001. Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J. Clin. Microbiol. 39:3437-41
41. Ivady G, Paldy L. 1958. Ein neues Behandlungsverfahren der interstitiellen plasmazelligen Pneu-monie Fruhgeborener mit funfwertigen Stibium und aromatischen Diamidinen. Monatsschr. Kinderheilkd. 106:10-15
42. KanaaniH,HargreavesM,RistovskiZ,MorawskaL.2007. Performance assessmentofUVAPS: influence of fungal spore age and air exposure. J. Aerosol Sci. 38:83-96
43. Kaneshiro ES. 2004. Sterol metabolism in the opportunistic pathogen Pneumocystis: advances and new insights. Lipids 39:753-61
44. Kaur N, Mahl TC. 2007. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Digest. Dis. Sci. 52:1481-84
45. Kazanjian P, Armstrong W, Hossler PA, Lee CH, Huang L, et al. 2001. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. J. Infect. Dis. 183:819-22
46. Kazanjian PH, Fisk D, Armstrong W, Shulin Q, Liwei H, et al. 2004. Increase in prevalence of Pneumo-cystis carinii mutations in patients with AIDS and P. carinii pneumonia in the United States and China. J. Infect. Dis. 189:1684-87
47. Keely SP, Baughman RP, Smulian AG, Dohn MN, Stringer JR. 1996. Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS 10:881-88
48. Keely SP, Cushion MT, Stringer JR. 2003. Diversityatthe locus associated with transcription ofavariable surface antigen of Pneumocystis carinii as an index of population structure and dynamics in infected rats. Infect. Immun. 71:47-60
49. Keely SP, Fischer JM, Cushion MT, Stringer JR. 2004. Phylogenetic identification of Pneumocystis murina sp. nov., a new species in laboratory mice. Microbiology 150:1153-65
50. Keely SP, Linke MJ, Cushion MT, Stringer JR. 2007. Pneumocystis murina MSG gene family and the structure of the locus associated with its transcription. Fungal Genet. Biol. 44:905-9
51. Keely SP, Renauld H, Wakefield AE, Cushion MT, Smulian AG, et al. 2005. Gene arrays at Pneumocystis carinii telomeres. Genetics 170:1589-600
52. Keely SP, Stringer JR. 2003. Sequence diversity of transcripts from Pneumocystis carinii gene families MSR and PRT1. J. Eukaryot. Microbiol. 50(Suppl.):627-28
53. Keely SP, Stringer JR. 2009. Complexity of the MSG gene family of Pneumocystis carinii. BMC Genomics 10:367
54. Keely SP, Stringer JR, Baughman RP, Linke MJ, Walzer PD, Smulian AG. 1995. Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J. Infect. Dis. 172:595-98
55. Keeney S, Giroux CN, Kleckner N. 1997. Meiosis-specific DNA double-strand breaks are catalyzed by Spo11, a member of a widely conserved protein family. Cell 88:375-84
56. Kovacs JA, Powell F, Edman JC, Lundgren B, Martinez A, et al. 1993. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J. Biol. Chem. 268:6034-40
57. Kutty G, Kovacs JA. 2003. A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jiroveci. Infect. Immun. 71:571-74
58. Kutty G, Maldarelli F, Achaz G, Kovacs JA. 2008. Variation in the major surface glycoprotein genes in Pneumocystis jirovecii. J. Infect. Dis. 198:741-49
59. Laakkonen J, Fisher RN, Case TJ. 2001. Pneumocystosis in wild small mammals from California. J. Wildl. Dis. 37:408-12
60. Laakkonen J, Haukisalmi V, Merritt JF. 1997. Lung parasites of shrews from Pennsylvania. J. Wildl. Dis. 33:285-89
61. Lee LH, Gigliotti F, Wright TW, Simpson-Haidaris PJ, Weinberg GA, Haidaris CG. 2000. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 242:141-50
62. Lugli EB, Bampton ET, Ferguson DJ, Wakefield AE. 1999. Cell-surface protease PRT1 identified in the fungal pathogen Pneumocystis carinii. Mol. Microbiol. 31:1723-33
63. Lythgoe KA, Morrison LJ, Read AF, Barry JD. 2007. Parasite-intrinsic factors can explain ordered progression of trypanosome antigenic variation. Proc. Natl. Acad. Sci. USA 104:8095-100
64. Mazars E, Guyot K, Fourmaintraux S, Renaud F, Petavy F, Camus D, Dei-Cas E. 1997. Detection of Pneumocystis in European wild animals. J. Eukaryot. Microbiol. 44:39S
65. Merali S, Vargas D, Franklin M, Clarkson AB Jr. 2000. S-adenosylmethionine and Pneumocystis carinii. J. Biol. Chem. 275:14958-63
66. Mills J. 1986. Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev. Infect. Dis. 8:1001-11
67. Monnet X, Vidal-Petiot E, Osman D, Hamzaoui O, Durrbach A, et al. 2008. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit. Care 12:R28
68. Morris A, Sciurba FC, Lebedeva IP, Githaiga A, Elliott WM, et al. 2004. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am. J. Respir. Crit. Care Med. 170:408-13
69. Nahimana A, Rabodonirina M, Bille J, Francioli P, Hauser PM. 2004. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob. Agents Chemother. 48:4301-5
70. Navin TR, Beard CB, Huang L, Del Rio C, Lee S, et al. 2001. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358:545-49
71. Nevez G, Magois E, Duwat H, Gouilleux V, Jounieaux V, Totet A. 2006. Apparent absence of Pneumocystis jirovecii in healthy subjects. Clin. Infect. Dis. 42:e99-101
72. O'Connell RJ, Panstruga R. 2006. Tete a tete inside a plant cell: establishing compatibility between plants and biotrophic fungi and oomycetes. New Phytol. 171:699-718
73. Olsson M, Sukura A, Lindberg LA, Linder E. 1996. Detection of Pneumocystis carinii DNA by filtration of air. Scand. J. Infect. Dis. 28:279-82
74. Palmer RJ, Settnes OP, Lodal J, Wakefield AE. 2000. Population structure of rat-derived Pneumocystis carinii in Danish wild rats. Appl. Environ. Microbiol. 66:4954-61
75. Patel N, Koziel H. 2004. Pneumocystis jiroveci pneumoniain adult patients with AIDS: treatment strategies and emerging challenges to antimicrobial therapy. Treat. Respir. Med. 3:381-97
76. Peglow SL, Smulian AG, Linke MJ, Pogue CL, Nurre S, et al. 1990. Serologic responses to Pneumocystis carinii antigens in health and disease. J. Infect. Dis. 161:296-306
77. Peterson JC, Cushion MT. 2005. Pneumocystis: not just pneumonia. Curr. Opin. Microbiol. 8:393-98
78. Radhi S, Alexander T, Ukwu M, Saleh S, Morris A. 2008. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. BMC Infect. Dis. 8:118
79. Ramage G, VandeWalle K, Wickes BL, Lopez-Ribot JL. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:163-70
80. Redhead SA, Cushion MT, Frenkel JK, Stringer JR. 2006. Pneumocystis and Trypanosoma cruzi: nomenclature and typifications. J. Eukaryot. Microbiol. 53:2-11
81. Schaffzin JK, Stringer JR. 2000. The major surface glycoprotein expression sites of two special forms of rat Pneumocystis carinii differ in structure. J. Infect. Dis. 181:1729-39
82. Schaffzin JK, Stringer JR. 2004. Expression of the Pneumocystis carinii major surface glycoprotein epitope is correlated with linkage of the cognate gene to the upstream conserved sequence locus. Microbiology 150:677-86
83. Schaffzin JK, Sunkin SM, Stringer JR. 1999. A new family of Pneumocystis carinii genes related to those encoding the major surface glycoprotein. Curr. Genet. 35:134-43
84. Sesterhenn TM, Slaven BE, Keely SP, Smulian AG, Lang BF, Cushion MT.2010. Sequenceand structure of the linear mitochondrial genome of Pneumocystis carinii. Mol. Genet. Genomics 283(1):63-72
85. Shultz LD, Schweitzer PA, Hall EJ, Sundberg JP, Taylor S, Walzer PD. 1989. Pneumocystis carinii pneumonia in scid/scid mice. Curr. Top. Microbiol. Immunol. 152:243-49
86. Skelly M, Hoffman J, Fabbri M, Holzman RS, Clarkson AB Jr, Merali S. 2003. S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Lancet 361:1267-68
87. Slaven BE, Meller J, Porollo A, Sesterhenn T, Smulian AG, Cushion MT. 2006. Draft assembly and annotation of the Pneumocystis carinii genome. J. Eukaryot. Microbiol. 53(Suppl. 1):S89-91 (Pubitemid 44813340)
88. Stringer JR. 2003. The MSG gene family and antigenic variation in the fungus P. carinii. In Antigenic Variation, ed. AG Craig, A Scherf, pp. 100-20. New York: Academic
89. Stringer JR. 2005. Surface antigens. In Pneumocystis Pneumonia, ed. PD Walzer, MT Cushion, pp. 95-126. New York: Marcel Dekker
90. Stringer SL, Garbe T, Sunkin SM, Stringer JR. 1993. Genes encoding antigenic surface glycoproteins in Pneumocystis from humans. J. Eukaryot. Microbiol. 40:821-26
91. Stringer SL, Hong ST, Giuntoli D, Stringer JR. 1991. Repeated DNA in Pneumocystis carinii. J. Clin. Microbiol. 29:1194-201
92. Stringer SL, Stringer JR, Blase MA, Walzer PD, Cushion MT. 1989. Pneumocystis carinii: sequence from ribosomal RNA implies a close relationship with fungi. Exp. Parasitol. 68:450-61
93. Sun L, Huang MJ, An YJ, Guo ZZ. 2009. An epidemiologic study on Pneumocystis pneumonia in non-HIV infected patients in China. Zhonghua Liu Xing. Bing. Xue. Za Zhi. 30:348-51
94. Sunkin SM, Linke MJ, McCormack FX, Walzer PD, Stringer JR. 1998. Identification of a putative precursor to the major surface glycoprotein of Pneumocystis carinii. Infect. Immun. 66:741-46
95. Sunkin SM, Stringer JR. 1996. Translocation of surface antigen genes to a unique telomeric expression site in Pneumocystis carinii. Mol. Microbiol. 19:283-95
96. Sunkin SM, Stringer JR. 1997. Residence at the expression site is necessary and sufficient for the transcription of surface antigen genes of Pneumocystis carinii. Mol. Microbiol. 25:147-60
97. Tellez I, Barragan M, Franco-Paredes C, Petraro P, Nelson K, Del Rio C. 2008. Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection. Am. J. Med. Sci. 335:192-97
98. Thomas M, Rupali P, Woodhouse A, Ellis-Pegler R. 2009. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV-infected patients. Scand. J. Infect. Dis. 17:1-7
99. Tsolaki AG, Miller RF, Underwood AP, Banerji S, Wakefield AE. 1996. Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia. J. Infect. Dis. 174:141-56
100. Tsolaki AG, Miller RF, Wakefield AE. 1999. Oropharyngeal samples for genotyping and monitoring response to treatment in AIDS patients with Pneumocystis carinii pneumonia. J. Med. Microbiol. 48:897-905
101. van der Meer MG, Brug SL. 1942. Infection a Pneumocystis chez l'homme et chez les animaux. Ann. Soc. Belge Maed. Trop. 22:301-9
102. Van Der Woude MW, Bäumler AJ. 2004. Phase and antigenic variation in bacteria. Clin. Microbiol. Rev. 17:581-611
103. Vanek J. 1951. Atypical interstitial pneumonia of infants produced by Pneumocystis carinii. Casop lék cesk 90:1121-30
104. Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, et al. 2001. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32:855-61
105. Vargas SL, Hughes WT, Wakefield AE, Oz HS. 1995. Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J. Infect. Dis. 172:506-10
106. Vavra J, Kucera K. 1970. Pneumocystis carinii Delanoe, its ultrastructure and ultrastructural affinities. J. Protozool. 17:463-83
107. Vohra PK, Park JG, Sanyal B, Thomas CF Jr. 2004. Expression analysis of PCSTE3, a putative pheromone receptor from the lung pathogenic fungus. Biochem. Biophys. Res. Commun. 319:193-99
108. Wada M, Nakamura Y. 1996. Unique telomeric expression site of major-surface-glycoprotein genes of Pneumocystis carinii. DNA Res. 3:55-64 (Pubitemid 126682797)
109. Wada M, Nakamura Y. 1999. Type-II major-surface-glycoprotein family of Pneumocystis carinii. J. Eu-karyot. Microbiol. 46:125S-6S
110. Wada M, Sunkin SM, Stringer JR, Nakamura Y. 1995. Antigenic variation by positional control of major surface glycoprotein gene expression in Pneumocystis carinii. J. Infect. Dis. 171:1563-68
111. Wakefield AE. 1996. DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J. Clin. Microbiol. 34:1754-59
112. Wakefield AE, Lindley AR, Ambrose HE, Denis CM, Miller RF. 2003. Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. J. Infect. Dis. 187:901-8
113. Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF. 2008. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin. Infect. Dis. 46:625-33
114. Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG. 1974. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann. Intern. Med. 80:83-93
115. Walzer PD, Smulian AG. 2010. Pneumocystis species. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, ed. GL Mandell, JE Bennet, and R Dolin, pp. 3377-90. Philadelphia: Elsevier
116. Wright TW, Gigliotti F, Haidaris CG, Simpson-Haidaris PJ. 1995. Cloning and characterization of a conserved region of human and rhesus macaque Pneumocystis carinii gpA. Gene 167:185-89
117. Zhang Q, Wise KS. 1997. Localized reversible frameshift mutation in an adhesin gene confers a phase-variable adherence phenotype in mycoplasma. Mol. Microbiol. 25:859-69